chr17-35422268-A-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_018042.5(SLFN12):c.761T>A(p.Met254Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000192 in 1,613,948 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_018042.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SLFN12 | NM_018042.5 | c.761T>A | p.Met254Lys | missense_variant | 2/4 | ENST00000304905.10 | |
SLFN12 | NM_001289009.2 | c.761T>A | p.Met254Lys | missense_variant | 2/4 | ||
SLFN12 | XM_005257995.6 | c.761T>A | p.Met254Lys | missense_variant | 3/5 | ||
SLFN12 | XM_024450822.2 | c.761T>A | p.Met254Lys | missense_variant | 4/6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SLFN12 | ENST00000304905.10 | c.761T>A | p.Met254Lys | missense_variant | 2/4 | 1 | NM_018042.5 | P1 | |
SLFN12 | ENST00000394562.5 | c.761T>A | p.Met254Lys | missense_variant | 4/6 | 1 | P1 | ||
SLFN12 | ENST00000452764.3 | c.761T>A | p.Met254Lys | missense_variant | 2/4 | 2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000854 AC: 13AN: 152192Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000358 AC: 9AN: 251212Hom.: 0 AF XY: 0.0000294 AC XY: 4AN XY: 135824
GnomAD4 exome AF: 0.0000123 AC: 18AN: 1461756Hom.: 0 Cov.: 35 AF XY: 0.00000688 AC XY: 5AN XY: 727176
GnomAD4 genome AF: 0.0000854 AC: 13AN: 152192Hom.: 0 Cov.: 33 AF XY: 0.0000807 AC XY: 6AN XY: 74336
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 17, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at